Browsing Tag
Sino-American Shanghai Squibb Pharmaceuticals
1 post
Why Bristol Myers Squibb is walking away from its first China joint venture after four decades
Bristol Myers Squibb’s 60% stake sale in its China JV shows a pivot from generics to innovation. Find out what this means for its stock and growth outlook.